跳至主要内容
临床试验/CTRI/2025/01/079724
CTRI/2025/01/079724尚未招募不适用

Effect of dexmedetomidine versus clonidine as an adjuvant to hyperbaric bupivacaine in subarachnoid block for the duration of analgesia in the patients undergoing infra umbilical surgeries

Dr Preeti Shirabur1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年2月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
duration of analgesia between dexmedetomidine and clonidine as an adjuvant

研究概览

简要总结

Dexmedetomidine being more potent drug compared to clonidine hence duration of analgesia will be longer in dexmedetomidine

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient willing to give informed consent
  • American Society of Anesthesiologists (ASA) physical status I or II
  • Age 18-60 years.
  • Elective infra umbilical surgical procedures requiring regional anesthesia.

排除标准

  • BMI below 18 or above 35 kg/m2
  • Presence with known contraindications for spinal anesthesia.
  • Preoperative intake of opioid or non-steroidal anti- inflammatory drugs for chronic pain.
  • Chronic hepatic or renal failure.

结局指标

主要结局

duration of analgesia between dexmedetomidine and clonidine as an adjuvant

时间窗: 6 hrs

to hyperbaric bupivacaine in spinal anesthesia for infra umbilical surgeries.

时间窗: 6 hrs

次要结局

  • 1. To compare the onset of sensory and motor block between dexmedetomidine and(clonidine.)

研究者

发起方
Dr Preeti Shirabur
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Preeti Shirabur

ESIC medical College and PGIMSR

研究点 (1)

Loading locations...

相似试验